Profile: Lorus Therapeutics Inc. is a biopharmaceutical company that focuses on the discovery, research and development of effective anticancer therapies with high safety profiles. We offer product candidates in three classes of anticancer therapies that include RNA-targeted therapies, small molecule platform and immunotherapy. Our LOR-2040 is an RNA-targeting agent that dramatically decreases the expression of the R2 subunit of ribonucleotide reductase. Our Interleukin-17E is a protein-based therapeutic developed as an immunotherapy for cancer treatment.